DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksSchließen
Referenz
Connolly SJ, Pogue J, Eikelboom J. et al.
ACTIVE W Investigators. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.
Circulation 2008;
118: 2029-2037.
Für die Inhalte der Internetseiten anderer Anbieter übernehmen wir keine Verantwortung.